NT5E and neoplasm: Recently, some researchers have found that the expression of CD73 in cancer cells limited the efficacy of immune response to immune checkpoint inhibitors and blockade of CD73 enhanced the anti‐tumour activity of anti‐PD‐1/PD‐L1.45